Early life programming of immune and lung function: can we now exclude a role of arachidonic acid exposure?
Calder
Philip C
PC
School of Medicine, Institute of Human Nutrition, University of Southampton, MP887 Southampton General Hospital, Tremona Road, Southampton, UK. pcc@soton.ac.uk
D016718:Arachidonic Acid / Q000502:physiology*; D001942:Breast Feeding; D002648:Child; D002675:Child, Preschool; D043371:Fatty Acids, Omega-6 / Q000009:adverse effects; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D019787:Linoleic Acid / Q000008:administration & dosage / Q000378:metabolism; D008168:Lung / Q000276:immunology; D008297:Male; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012129:Respiratory Function Tests; D016176:T-Lymphocyte Subsets / Q000276:immunology
D043371:Fatty Acids, Omega-6; D016718:Arachidonic Acid; D019787:Linoleic Acid